Brief: MiMedx Q2 Sales USD 64.362 Million Vs. IBES Estimate USD 63.5 Million
29/07/2026 21:08
BRIEF-MiMedx Q2 Sales USD 64.362 Million Vs. IBES Estimate USD 63.5 Million Jul 29 (Reuters) - MiMedx Q2 gross profit USD 44.381 million.
- Q2 adjusted EBITDA USD -8.121 million vs. IBES estimate USD 2.06 million
- Q2 net income USD -14.84 million
- Q2 operating income USD -18.466 million
- outlook FY sales USD 260-290 million vs. IBES estimate USD 269.4 million
Recent news on MiMedx
See all newsBrief: Mimedx Announces Favorable Federal Court Ruling In Axiofill® Regulatory Classification Matter
MiMedx Group Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Mimedx To Acquire Sanara Medtech
MiMedx Q2 sales fall less than expected; set to acquire Sanara MedTech
Brief: MiMedx Q2 Sales USD 64.362 Million Vs. IBES Estimate USD 63.5 Million